Anterogen Co (XKRX:065660) Total Liabilities : ₩6,404 Mil (As of Mar. 2024)

View and export this data going back to 2016. Start your Free Trial

What is Anterogen Co Total Liabilities?

Anterogen Co's Total Liabilities for the quarter that ended in Mar. 2024 was ₩6,404 Mil.

Anterogen Co's quarterly Total Liabilities declined from Sep. 2023 (₩22,375.73 Mil) to Dec. 2023 (₩19,986.74 Mil) and declined from Dec. 2023 (₩19,986.74 Mil) to Mar. 2024 (₩6,404.24 Mil).

Anterogen Co's annual Total Liabilities declined from Dec. 2021 (₩19,834.17 Mil) to Dec. 2022 (₩17,341.33 Mil) but then increased from Dec. 2022 (₩17,341.33 Mil) to Dec. 2023 (₩19,986.74 Mil).

Anterogen Co Total Liabilities Historical Data

The historical data trend for Anterogen Co's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Anterogen Co Total Liabilities Chart

Anterogen Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Total Liabilities

Get a 7-Day Free Trial

16,200.12

13,137.04

19,834.17

17,341.33

19,986.74

Anterogen Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Total Liabilities	Get a 7-Day Free Trial															18,393.14	16,240.35	22,375.73	19,986.74	6,404.24

Anterogen Co Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Anterogen Co's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	10758.759	+	(0	+	8918.264
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	309.717)
	=	19,987

Total Liabilities	=	Total Assets (A: Dec. 2023 )	-	Total Equity (A: Dec. 2023 )
	=	149431.677	-	129444.937
	=	19,987

Anterogen Co's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities	=	Total Current Liabilities	+	Total Noncurrent Liabilities
	=	Total Current Liabilities	+	(Long-Term Debt & Capital Lease Obligation	+	Other Long-Term Liabilities
	=	924.92	+	(0	+	5147.437
	+	NonCurrent Deferred Liabilities	+	PensionAndRetirementBenefit)
	+	0	+	331.881)
	=	6,404

Total Liabilities	=	Total Assets (Q: Mar. 2024 )	-	Total Equity (Q: Mar. 2024 )
	=	121092.265	-	114688.027
	=	6,404

Anterogen Co Total Liabilities Related Terms

Thank you for viewing the detailed overview of Anterogen Co's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.

Anterogen Co (XKRX:065660) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Anterogen Co Ltd (XKRX:065660) » Definitions » Total Liabilities

Comparable Companies

Traded in Other Exchanges

N/A

Address

Namsung Plaza, Gasan-dong, 405, 130, Digital-ro, Geumcheon-gu, Seoul, KOR, 08589

Website

http://www.anterogen.com

Anterogen Co Ltd is a bio-venture company engaged in the research and development of cell therapy products and orphan drugs using adult stem cells. Its products include Cupistem injection, Queen cell, Remodulin injection, and TheraStem-Derma. The company also offers cell banking services and analysis services that include sample analysis for clinical studies.

Anterogen Co (XKRX:065660) Headlines

No Headlines